Integrated Wealth Concepts’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$957K Buy
+12,824
New +$944K 0.01% 1291

Other funds holding KNSA

Integrated Wealth Concepts's KNSA Position: Q3 2026 in Review

Integrated Wealth Concepts opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 12,824 shares worth $957K. The stake represents 0.01% of the portfolio and ranks #1291 among its holdings.

305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Integrated Wealth Concepts held 12,824 shares of Kiniksa Pharmaceuticals worth $957K as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new Integrated Wealth Concepts position in Q3 2026.
  • Kiniksa Pharmaceuticals made up 0.01% of Integrated Wealth Concepts's portfolio in Q3 2026, its #1291 holding.
  • 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Integrated Wealth Concepts's 13F filing for Q3 2026, filed 17 Nov 2026.